Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Máiz
L
L
Unidad de Fibrosis Quística, Hospital Ramón y Cajal, Madrid, Spain.
Cantón
R
R
Mir
N
N
Baquero
F
F
Escobar
H
H
D000280:Administration, Inhalation; D000336:Aerosols; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D016106:Methicillin Resistance; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects; D014640:Vancomycin / Q000008:administration & dosage* / Q000627:therapeutic use
D000336:Aerosols; D000900:Anti-Bacterial Agents; D014640:Vancomycin